This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Walter N. Pahnke, MD, PhD; Albert A. Kurland, MD; Sanford Unger, PhD; Charles Savage, MD; Stanislav Grof, MD

JAMA. 1970;212(11):1856-1863.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The history of research with psychedelic drugs has produced a variety of methods for their use and conflicting claims about results. First came the wave of excitement among experimentalists in the 1950s when it was claimed that lysergic acid diethylamide (LSD) could produce a model psychosis which might be useful in understanding schizophrenia. While this promise was fading, enthusiastic reports about the possibility of LSD as an aid to psychotherapy in the treatment of alcoholism and other psychiatric disorders appeared. All these approaches were represented in 1959 at the first international conference devoted entirely to LSD.¹ Since then, there have been at least five more published proceedings of such conferences on various aspects of psychedelic drugs.^2-6 The most recent conference on various means of producing states of consciousness was sponsored by the Menninger Foundation and the American Association of Humanistic Psychology on April 7 to 11, 1969, in . . . [Full Text PDF of this Article]

Author Affiliations
From the Maryland State Psychiatric Research Center, the Johns Hopkins University School of Medicine (Drs. Pahnke, Unger, Savage, and Grof), and the Department of Mental Hygiene, State of Maryland (Dr. Kurland), Baltimore.

Footnotes
Read before the Symposium on Psychedelic Drugs at the 118th annual convention of the American Medical Association, New York, July 17, 1969. Based partially on a presentation by Albert Kurland, MD, at the American College of Neuropsychopharmacology, San Juan, Puerto Rico, Dec 20, 1968.

Reprint requests to Maryland Psychiatric Research Center, Box 3235, Baltimore 21228 (Dr. Pahnke).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?